## **Core Concept**
SSPE (Subacute Sclerosing Panencephalitis) is a rare but chronic and progressive complication of measles infection, caused by a persistent measles virus infection in the brain. The disease primarily affects children and young adults. The treatment of SSPE involves antiviral and immunomodulatory therapies.

## **Why the Correct Answer is Right**
The correct answer, **Ribavirin and Isoprinosine (or Inosine Pranobex)**, involves the use of antiviral agents. Isoprinosine has been shown to have some benefit in the treatment of SSPE, although its mechanism of action is not fully understood. Ribavirin, an antiviral medication, has also been used in combination with other treatments for SSPE. This combination can help in modulating the immune response and possibly reducing viral replication.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not represent a recognized treatment for SSPE.
- **Option B:** This option might include treatments not established for SSPE or might not combine therapies known to have a synergistic effect.
- **Option D:** This option could include drugs not typically used for SSPE or might suggest a monotherapy approach, which is less effective than combination therapy.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for SSPE is that it is a complication of measles, and its occurrence can be prevented by measles vaccination. Early recognition and treatment can potentially improve outcomes. Isoprinosine, along with supportive care, has been a part of the therapeutic regimen for some patients.

## **Correct Answer:** C. Ribavirin and Isoprinosine.